licensing agreement

Name: NJBIZ 2026 ARTIFICIAL INTELLIGENCE PANEL DISCUSSION
Start: 2026-07-29T13:00:00-04:00
End: 2026-07-29T14:30:00-04:00
Location: Virtual Panel Discussion

May 12, 2026

Bristol Myers Squibb inks $15.2B drug deal with Hengrui

The partnership with Hengrui Pharma will develop 13 oncology, hematology and immunology drug programs worldwide.

Latest Headlines

NJBIZ Conversations

Hackensack Meridian Health President and COO Mark Sparta speaks with NJBIZ Editor Jeff Kanige on May 14, 2026.

NJBIZ Conversations | SPECIAL EDITION: Hackensack Meridian Health[...]

Hackensack Meridian Health COO Mark Sparta discusses the health system's new facility in MetroPark and th[...]

Select Region or Brand

Upcoming Event

licensing agreement

Bristol Myers Squibb inks $15.2B drug deal with Hengrui

Latest Headlines

HLW names co-studio directors for New Jersey office

PSE&G restores power to 380K after New Jersey storms (photos)

Zeppelin Hall hosts World Cup watch parties in Jersey City

Namkeen opens 10th restaurant in North Brunswick

Hopeworks opens Newark workforce development hub

NJBIZ Conversations

NJBIZ Conversations | SPECIAL EDITION: Hackensack Meridian Health[...]

Events

licensing agreement

Bristol Myers Squibb inks $15.2B drug deal with Hengrui

NJBIZ Daily Newsletter

Latest Headlines

HLW names co-studio directors for New Jersey office

PSE&G restores power to 380K after New Jersey storms (photos)

Zeppelin Hall hosts World Cup watch parties in Jersey City

Namkeen opens 10th restaurant in North Brunswick

Hopeworks opens Newark workforce development hub

NJBIZ Conversations

NJBIZ Conversations | SPECIAL EDITION: Hackensack Meridian Health[...]

Events